Guidelines for the use of radio-iodine, thyroid hormone, and treatment of metastatic disease in patients with differentiated thyroid cancer

Surgical Oncology Clinics of North America

Volumn 7, Issue 4, 1998, Pages 665-680

  Paloyan, E ^a   Paloyan, R ^a   Lawrence, W A M ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE; THYROID HORMONE;

BONE METASTASIS; CANCER INVASION; CANCER RECURRENCE; CERVICAL LYMPH NODE; DIAGNOSTIC IMAGING; DISEASE ACTIVITY; HUMAN; LUNG METASTASIS; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; REVIEW; THYROID CANCER; THYROID PARAFOLLICULAR CELL;

EID: 0031721605     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1055-3207(18)30239-4     Document Type: Review

References (37)

1. Attie J. Bock G. Postoperative radioactive iodine evaluation of total thyroidectomy for thyroid carcinoma; Reappraisal and therapeutic implications Head Neck 82 1991 297
2. Baskin H.J. Nevitt M.C. Ettinger B. Prognosis and treatment of brain metastases in thyroid carcinoma J Clin Endocrinol Metab 82 1997 3637 3642
3. Bauer D. Low Thyrotropin levels are not associated with bone loss in older women: A prospective study J Clin Endocrinol Metab 82 1997 2931
4. 131I therapy in Europe Thyroid 7 1997 221
5. Bitton R. Sachmechi I. Wright J. Leukemia after a small dose of radioiodine for metastatic thyroid cancer J Clin Endocrinol and Metab 77 1993 1423
6. Blum M. Yee J. Advances in thyroid imaging: Thyroid sonography: When and how should it be used? Thyroid Today 20 1997 1
7. Burmeister L. Thyroid hormone in the treatment of thyroid cancer Thyroid Today 17 1994 1
8. Chiu A.C. Wang L. Thyroid ultrasonography—A review Endocr Practice 3 1997 153
9. Dow K. Ferrell B. Quality-of-life changes in patients with thyroid cancer after withdrawal of thyroid hormone therapy Thyroid 7 1997 613
10. Dulgeroff A. Hershman J. Medical therapy for differentiated thyroid carcinoma Endocr Rev 15 1994 500
11. Emerson C. Foster D. Pearu S. Epithelial cell thyroid cancer and thyroid stimulating hormone—When less is more (editorial) J Clin Endocrinol Metab 82 1996 9
12. Grillo H.C. Mavroudis S. Kirchner J. Resectional management of thyroid carcinoma invading the airway Ann Thorac Surg 54 1992 3
13. 99mTc-Sestamibi scintigraphy in differentiated thyroid cancer Thyroid 7 1997 327
14. Hall P. Holm L. Late consequences of radioiodine for diagnosis and therapy in Sweden Thyroid 7 1997 205
15. Ladenson P. Braverman L.E. Mazzaferri E.L. Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma N Engl J Med 337 1997 888
16. Langdahl D. Bauer A.D. James L. Effect of long term L-thyroxine therapy on bone mass in hypothyroid patients Eur J Endocrinol 134 1996 702
17. Maxon H. Englaro E.E. Thomas S.R. Radioiodine-131 therapy for well-differentiated thyroid cancer—A quantitative radiation dosimetric approach: Outcome and validation in 85 patients J Nucl Med 33 1992 1132
18. 131I in the treatment of thyroid cancer Thyroid Today 16 1993 1
19. Maxon H. Thomas S. Samaratunga R.C. Dosimetric considerations in the radioiodine treatment of macrometastases and micrometastases from differentiated thyroid cancer Thyroid 7 1997 183
20. 131I ablation for papillary and follicular thyroid carcinoma Thyroid 7 1997 265
21. 131I negative whole body scan, and positive thyroglobulin in differentiated thyroid carcinoma: What is being treated? Thyroid 7 1997 669
22. Morris J. Kim C. Conversion of non-iodine-concentrating differentiated thyroid carcinoma metastases into iodine-concentrating foci after anticancer chemotherapy Thyroid 7 1997 63
23. Nguyen T. Heath H. Fractures after thyroidectomies in men: A population-based cohort study J Bone Miner Res 12 1997 1092
24. Pacini F. Lippi F. Formica N. Effect of radioiodine treatment for thyroid cancer on testicular function J Nucl Med 35 1994 1418
25. Park H. Perkins O.W. Edmondson J.W. Influence of diagnostic radioiodines on the uptake of ablative dose of iodine-131 Thyroid 4 1994 49
26. 131I scanning J Clin Nucl Med 17 1992 501
27. Park H. Park Y. Zhou X. Detection of thyroid remnant/metastasis without stunning: An ongoing dilemma Thyroid 7 1997 277
28. Pineda J. Depiree L.T. Robbins J. Treating metastatic thyroid cancer The Endocrinologist 3 1993 433
29. Ramirez L. Braverman L. White B. Recombinant human thyrotropin is a potent stimulator of thyroid function in normal subjects J Clin Endocrinol Metab 82 1997 2836
30. Raymond J. Izembart V. Temporary ovarian failure in thyroid cancer patients after thyroid remnant ablation with radioactive iodine J Clin Endocrinol Metab 69 1989 186
31. 131I scans: Their role in the management of thyroid cancer Thyroid 7 1997 281
32. 131I and recombinant human thyroid stimulating hormone J Clin Endocrinol Metab 82 1997 11
33. 131I therapy for elevated thyroglobulin levels Thyroid 7 1997 273
34. Shah D. Samuel A. Metastasis to the liver in well-differentiated carcinoma of the thyroid Thyroid 6 1996 607
35. Solomon B. Prevalence of fractures in postmenopausal women with thyroid disease Thyroid 3 1993 17
36. Walfish P.G. Diagnostic and treatment dilemmas in thyroid carcinoma Paloyan E. LiVolsi V.A. Becker D.B. et al Proceedings of the American Association of Clinical Endocrinologists 1995
37. Wyngaarden K. McDougall I. Is serum thyroglobulin a useful marker for thyroid cancer in patients who have not had ablation of residual thyroid tissue? Thyroid 7 1997 343